Neurobiology of Anxiety Disorders

E. Hollander, P. Palkar
{"title":"Neurobiology of Anxiety Disorders","authors":"E. Hollander, P. Palkar","doi":"10.2310/NEURO.13021","DOIUrl":null,"url":null,"abstract":"In recent years, advances in the fields of neuroimaging and experimental psychology increased our understanding of the basic mechanisms of classical conditioning and learning, contributing to our knowledge of the neurobiology of anxiety disorders. Research has shown that the amygdala is the cornerstone of fear circuitry and that abnormalities in amygdala pathways can affect the acquisition and expression of fear conditioning. Activation of the amygdala in response to disorder-relevant stimuli has been observed in anxiety disorders. The roles of the hippocampus, nucleus accumbens, periaqueductal gray, and insular and medial prefrontal cortices in response to fear have been identified as well. Neurotransmitters such as serotonin, dopamine, γ-aminobutyric acid, glutamate, and some neurosteroids play an important part in the neurobiology of anxiety disorders. Neuropeptides such as oxytocin, neuropeptide Y, galanin, and cholecystokinin have been shown to modulate stress response. Drugs such as N-methyl-d-aspartate (NMDA) antagonists and blockers of voltage-gated calcium channels in the amygdala are anxiolytic. Fear extinction, which entails new learning of fear inhibition, is the mechanism of effective antianxiety treatments such as d-cycloserine, a partial NMDA agonist. Extinction is thought to occur by the medial prefrontal cortex, which inhibits the lateral amygdala under hippocampal modulation. Harnessing extinction to delink neutral stimuli from aversive responses is an important goal of the psychotherapy and pharmacotherapy of anxiety disorders. Discovery of the role of microRNAs in the etiology of anxiety disorders and their possible utility as targets to treat these disorders is fascinating. In this review, we discuss the neurobiology of anxiety disorders, which will help us better manage them clinically.\nThis review contains 5 figures, 6 tables, and 39 references.\nKey words: Amygdala, anxiety disorders, neurobiology, fear conditioning, neurocircuitry, neurotransmitters, neuropeptides, neurosteroids, endogenous opioids.","PeriodicalId":142272,"journal":{"name":"DeckerMed Neurology","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"DeckerMed Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2310/NEURO.13021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In recent years, advances in the fields of neuroimaging and experimental psychology increased our understanding of the basic mechanisms of classical conditioning and learning, contributing to our knowledge of the neurobiology of anxiety disorders. Research has shown that the amygdala is the cornerstone of fear circuitry and that abnormalities in amygdala pathways can affect the acquisition and expression of fear conditioning. Activation of the amygdala in response to disorder-relevant stimuli has been observed in anxiety disorders. The roles of the hippocampus, nucleus accumbens, periaqueductal gray, and insular and medial prefrontal cortices in response to fear have been identified as well. Neurotransmitters such as serotonin, dopamine, γ-aminobutyric acid, glutamate, and some neurosteroids play an important part in the neurobiology of anxiety disorders. Neuropeptides such as oxytocin, neuropeptide Y, galanin, and cholecystokinin have been shown to modulate stress response. Drugs such as N-methyl-d-aspartate (NMDA) antagonists and blockers of voltage-gated calcium channels in the amygdala are anxiolytic. Fear extinction, which entails new learning of fear inhibition, is the mechanism of effective antianxiety treatments such as d-cycloserine, a partial NMDA agonist. Extinction is thought to occur by the medial prefrontal cortex, which inhibits the lateral amygdala under hippocampal modulation. Harnessing extinction to delink neutral stimuli from aversive responses is an important goal of the psychotherapy and pharmacotherapy of anxiety disorders. Discovery of the role of microRNAs in the etiology of anxiety disorders and their possible utility as targets to treat these disorders is fascinating. In this review, we discuss the neurobiology of anxiety disorders, which will help us better manage them clinically. This review contains 5 figures, 6 tables, and 39 references. Key words: Amygdala, anxiety disorders, neurobiology, fear conditioning, neurocircuitry, neurotransmitters, neuropeptides, neurosteroids, endogenous opioids.
焦虑症的神经生物学
近年来,神经影像学和实验心理学领域的进展增加了我们对经典条件反射和学习的基本机制的理解,有助于我们了解焦虑症的神经生物学。研究表明,杏仁核是恐惧回路的基石,杏仁核通路的异常会影响恐惧条件反射的获得和表达。在焦虑障碍中观察到杏仁核对障碍相关刺激的反应。海马体、伏隔核、导水管周围灰质、脑岛和内侧前额叶皮层在恐惧反应中的作用也已被确定。神经递质如血清素、多巴胺、γ-氨基丁酸、谷氨酸和一些神经类固醇在焦虑症的神经生物学中起着重要作用。神经肽如催产素、神经肽Y、丙氨酸和胆囊收缩素已被证明可以调节应激反应。诸如n -甲基-d-天冬氨酸(NMDA)拮抗剂和杏仁核电压门控钙通道阻滞剂等药物具有抗焦虑作用。恐惧消除,需要对恐惧抑制的新学习,是有效的抗焦虑治疗的机制,如d-环丝氨酸,部分NMDA激动剂。消失被认为发生在内侧前额叶皮层,在海马调节下抑制外侧杏仁核。利用消退将中性刺激从厌恶反应中分离出来是焦虑症心理治疗和药物治疗的一个重要目标。发现微rna在焦虑症病因学中的作用以及它们作为治疗这些疾病的靶点的可能用途是令人着迷的。在这篇综述中,我们讨论焦虑症的神经生物学,这将有助于我们更好地管理他们的临床。本综述包含5个图,6个表,39篇参考文献。关键词:杏仁核,焦虑障碍,神经生物学,恐惧调节,神经回路,神经递质,神经肽,神经类固醇,内源性阿片样物质
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信